NCT04886726View on ClinicalTrials.gov

PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis

PHASE1RecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 23, 2021

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2027

Conditions
Graft Versus Host Disease
Interventions
DRUG

uhCG/EGF

PTCY for 2 doses on day +3 and +4 after stem cell transplant followed by uhCG/EGF subcutaneously on day +7, +9 and +11 post stem cell transplant

Trial Locations (1)

48202

RECRUITING

Henry Ford Hospital, Detroit

All Listed Sponsors
lead

Henry Ford Health System

OTHER